Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.

Md S, Khan RA, Mustafa G, Chuttani K, Baboota S, Sahni JK, Ali J.

Eur J Pharm Sci. 2013 Feb 14;48(3):393-405. doi: 10.1016/j.ejps.2012.12.007. Epub 2012 Dec 21.

PMID:
23266466
2.

Optimised nanoformulation of bromocriptine for direct nose-to-brain delivery: biodistribution, pharmacokinetic and dopamine estimation by ultra-HPLC/mass spectrometry method.

Md S, Haque S, Fazil M, Kumar M, Baboota S, Sahni JK, Ali J.

Expert Opin Drug Deliv. 2014 Jun;11(6):827-42. doi: 10.1517/17425247.2014.894504. Epub 2014 Mar 22.

PMID:
24655115
3.

Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting.

Jafarieh O, Md S, Ali M, Baboota S, Sahni JK, Kumari B, Bhatnagar A, Ali J.

Drug Dev Ind Pharm. 2015;41(10):1674-81. doi: 10.3109/03639045.2014.991400. Epub 2014 Dec 11.

PMID:
25496439
4.

Brain targeted nanoparticulate drug delivery system of rasagiline via intranasal route.

Mittal D, Md S, Hasan Q, Fazil M, Ali A, Baboota S, Ali J.

Drug Deliv. 2016;23(1):130-9. doi: 10.3109/10717544.2014.907372. Epub 2014 Apr 30.

PMID:
24786489
5.

Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.

Fazil M, Md S, Haque S, Kumar M, Baboota S, Sahni JK, Ali J.

Eur J Pharm Sci. 2012 Aug 30;47(1):6-15. doi: 10.1016/j.ejps.2012.04.013. Epub 2012 Apr 27.

PMID:
22561106
6.

Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats.

Zhang X, Liu L, Chai G, Zhang X, Li F.

Drug Dev Ind Pharm. 2013 Nov;39(11):1618-24. doi: 10.3109/03639045.2012.727828.

PMID:
24087853
7.

Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting.

Wang X, Chi N, Tang X.

Eur J Pharm Biopharm. 2008 Nov;70(3):735-40. doi: 10.1016/j.ejpb.2008.07.005. Epub 2008 Jul 18.

PMID:
18684400
8.

Venlafaxine loaded chitosan NPs for brain targeting: pharmacokinetic and pharmacodynamic evaluation.

Haque S, Md S, Fazil M, Kumar M, Sahni JK, Ali J, Baboota S.

Carbohydr Polym. 2012 Jun 5;89(1):72-9. doi: 10.1016/j.carbpol.2012.02.051. Epub 2012 Feb 28.

PMID:
24750606
9.

Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study.

Alam S, Khan ZI, Mustafa G, Kumar M, Islam F, Bhatnagar A, Ahmad FJ.

Int J Nanomedicine. 2012;7:5705-18. doi: 10.2147/IJN.S35329. Epub 2012 Nov 9.

10.

Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route.

Patel S, Chavhan S, Soni H, Babbar AK, Mathur R, Mishra AK, Sawant K.

J Drug Target. 2011 Jul;19(6):468-74. doi: 10.3109/1061186X.2010.523787. Epub 2010 Oct 19.

PMID:
20958095
11.

Intranasal nanoemulsion based brain targeting drug delivery system of risperidone.

Kumar M, Misra A, Babbar AK, Mishra AK, Mishra P, Pathak K.

Int J Pharm. 2008 Jun 24;358(1-2):285-91. doi: 10.1016/j.ijpharm.2008.03.029. Epub 2008 Mar 27.

PMID:
18455333
12.

Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain.

Hanafy AS, Farid RM, ElGamal SS.

Drug Dev Ind Pharm. 2015;41(12):2055-68. doi: 10.3109/03639045.2015.1062897. Epub 2015 Jul 2.

PMID:
26133084
13.

Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.

Bagre AP, Jain K, Jain NK.

Int J Pharm. 2013 Nov 1;456(1):31-40. doi: 10.1016/j.ijpharm.2013.08.037. Epub 2013 Aug 29.

PMID:
23994363
14.

"Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ".

Shah B, Khunt D, Misra M, Padh H.

Int J Biol Macromol. 2016 Aug;89:206-18. doi: 10.1016/j.ijbiomac.2016.04.076. Epub 2016 Apr 27.

PMID:
27130654
15.

Nose-to-brain delivery of tacrine.

Jogani VV, Shah PJ, Mishra P, Mishra AK, Misra AR.

J Pharm Pharmacol. 2007 Sep;59(9):1199-205.

PMID:
17883890
16.

Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by AIDS viruses.

Al-Ghananeem AM, Saeed H, Florence R, Yokel RA, Malkawi AH.

J Drug Target. 2010 Jun;18(5):381-8. doi: 10.3109/10611860903483396.

PMID:
20001275
17.

Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.

Saini D, Fazil M, Ali MM, Baboota S, Ali J.

Drug Deliv. 2015;22(6):823-36. doi: 10.3109/10717544.2014.900153. Epub 2014 Apr 14.

PMID:
24725026
18.

Nose-To-Brain Delivery of PLGA-Diazepam Nanoparticles.

Sharma D, Sharma RK, Sharma N, Gabrani R, Sharma SK, Ali J, Dang S.

AAPS PharmSciTech. 2015 Oct;16(5):1108-21. doi: 10.1208/s12249-015-0294-0. Epub 2015 Feb 21.

19.

Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of Cerebral Ischemia.

Ahmad N, Ahmad R, Naqvi AA, Alam MA, Ashafaq M, Samim M, Iqbal Z, Ahmad FJ.

Int J Biol Macromol. 2016 Oct;91:640-55. doi: 10.1016/j.ijbiomac.2016.06.001. Epub 2016 Jun 2.

PMID:
27264648
20.

Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review.

Kulkarni AD, Vanjari YH, Sancheti KH, Belgamwar VS, Surana SJ, Pardeshi CV.

J Drug Target. 2015;23(9):775-88. doi: 10.3109/1061186X.2015.1020809. Epub 2015 Mar 11. Review.

PMID:
25758751

Supplemental Content

Support Center